Metabolic fate of TAT 59 (3rd Report): Absorption and metabolism of TAT- 59

Japanese Pharmacology and Therapeutics

Volumn 26, Issue 5, 1998, Pages 151-161

  Ikeda, Kazumasa ^a   Nagamachi, Masahiro ^a   Masuda, Hirotoshi ^a   Nagayama, Sekio ^a   Kawaguchi, Yasuro ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Absorption; Alkaline phosphatase; CYP3A4; Metabolism; Miproxifene phosphate; P 450; Rat; TAT 59

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; MIPROXIFENE PHOSPHATE; PROADIFEN;

ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; BREAST TUMOR; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DEPHOSPHORYLATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0031714596     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Toko T et al: TAT-59, a new triphenyl-ethylene derivative with antitumor activity against hormone dependent tumors. Eur J Cancer 26: 397-404, 1990
2. Iino Y et al: A new triphenylethylene derivative, TAT-59; Hormone receptors; Insulin-like growth factor 1; And growth suppression of hormone - dependent MCF-7 tumors in athymic mice. Cancer Chemother Pharmacol 34: 372-376, 1994
3. Ogawa K et al: Synthesis and antiestrogenic activity of the compounds related to the metabolites of (E)-4-[1-[4-[2-(dimethylamino)ethoxy] phenyl]-2-(4-isopropylphenyl)-1-butenyl] phenyl monophosphate (TAT-59). Chem Pharm Bull 39: 911-916, 1991
4. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
5. Tardivel S et al: In vitro inhibition of alkaline phosphatase activities from intestine, bone, liver, and kidney by phenobarbital. Enzyme 46: 276-283, 1992
6. th International Congress of Chemotherapy. Abstract 3038, 1995
7. Shimada T et al: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals; Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414-423, 1994
8. Françoise J et al: Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxyfen in human liver microsomes. Biochem Pharmacol 41: 1911-1919, 1991
9. Crewe HK et al: Various contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem Pharmacol 53: 171-178, 1997
10. Françoise M et al: Hepatic biotransformation of docetaxel (Taxotere ®) in vitro; Involvement of the CYP 3 A subfamily in humans. Cancer Research 56: 1296-1302, 1996
11. Kivistö KT et al: The role of human cytochrome P 450 enzymes in the metabolism of anticancer agents; Implications for drug interactions. Br J Clin Pharmacol 40: 523-530, 1995